I’m gift-wrapping this trade today…

Good news…

You’ve got a nice and easy trade plan laid out for this morning!

Personally, I love trading this stock when it’s on the radar of financial professionals, just like it is today!

I actually day-traded it for myself yesterday…


And today I’ve got the exact trade plan and option contracts I want to trade laid out ahead of time as well.

Ticker Code Ticker Name Ticker Industry Price Change Average Volume (50)*
IBIO Ibio Inc Biotechnology 65.65% 39,092,887
TSLA Tesla Inc Auto Manufacturers 41.46% 15,314,364
NIO Nio Inc – ADR Auto Manufacturers 51.34% 164,608,593
MVIS Microvision, Inc. Scientific & Technical Instruments 48.77% 13,802,772
SMTI Sanara Medtech Inc Surgical appliances and supplies -5.71% 6,138
HTBX Heat Biologics Inc Biotechnology 57.00% 44,077,280
INO Inovio Pharmaceuticals Inc Biotechnology 42.86% 47,865,274
MRNA Moderna Inc Biotechnology 25.65% 27,570,443
SPOT Spotify Technology SA Internet Content & Information 31.93% 4,275,650
AMD Advanced Micro Devices, Inc. Semiconductors 22.16% 59,526,811
MSFT Microsoft Corporation Software – Infrastructure 9.45% 35,459,490
AMZN Amazon.com, Inc. Internet Retail 17.99% 5,177,464
XSPA XpresSpa Group Inc Personal Services -71.17% 9,146,336
AAPL Apple Inc. Consumer Electronics 13.59% 35,232,398
SRNE Sorrento Therapeutics Inc Biotechnology 48.60% 24,858,605
AZN AstraZeneca plc Drug Manufacturers – General 4.35% 9,199,949
BNGO BioNano Genomics Inc Diagnostics & Research 34.94% 33,516,663
NFLX Netflix Inc Entertainment 15.18% 9,028,372
ATGN AltiGen Communications, Inc. Telephone and telegraph apparatus 20.93% 45,944
TTOO T2 Biosystems Inc Diagnostics & Research 25.79% 16,331,980

Set to report earnings on August 10, Inovio Pharmaceuticals (INO) remains one of most active biotech stocks on the unusual options activity tape on a day-to-day basis.

Why is INO frequently traded by the biggest money players in the stock market?

The stock often encounters financial catalyst events, is troubled by questionable business ethics of its upper management staff, and oscillates in and out of the COVID vaccine running.

Bottom line, the stock has enough “skin in the game” to move on news.

Wall Street often knows what the news is ahead of time, and therefore places bullish or bearish bets on INO while most retail traders are left in the dark.

Fortunately, my paid software has identified where INO’s biggest-money option players are today…

On July 27 an option player stepped in and bought $49K worth of INO August 21 30 Calls

I didn’t take this move for myself as markets weren’t in a place where I was willing to digest the risk which comes with trading out-of-the money (OTM) call options on a biotech stock.

Rather, I added it to my watchlist, and with INO trading right above its 50-day simple moving average line support (red line above), today might be a day to consider making a move – market depending.

Today I’ll be watching my paid software for possible INO unusual call option sweeps.

If INO can hold its 50-day simple moving average line support, I’ll likely make a move on it with the goal of capturing triple-digit returns in 72 hours or less.

And if I do, I’ll be sure to let you know in my afternoon watchlist.

Let me know how YOU do today!

Oh, by the way, I detailed INO and a couple other stocks I’m watching in a premarket video I made this morning. You can watch it right here.


Davis Martin
America’s #1 Options Trader
@DavisMartin88
@DavisMartin88
@DavisMartin88

Disclaimer: This is not investment advice. This article is for information purposes only and opinion-based on financial advisor data across a selection of websites. Investors should be cautious about any and all investments and are advised to conduct their own due diligence prior to making any investment decisions.

Related posts

Electric Cars and Spaceships

Davis Martin

This Company Is Suspicious. Here’s How I’m Playing It.

Davis Martin

Morgan Stanley’s #1 Stock Inside…

Davis Martin

Billions of Dollars Could Be Traded via this Stock Today

Davis Martin

Smart Money Loves These Stocks…

Davis Martin

Warren Buffett Sold This Stock for a Reason!

Davis Martin